![Giacomo Salvadore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Giacomo Salvadore worked as Vice President-Translational Medicine at ACADIA Pharmaceuticals, Inc. Dr. Salvadore worked as Chief Medical Officer at Alector, Inc. from 2025 to 2026.
Dr. Salvadore earned a doctorate from Università degli Studi di Roma Tor Vergata.
Ehemalige bekannte Positionen von Giacomo Salvadore
| Unternehmen | Position | Ende |
|---|---|---|
| ALECTOR, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2026 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
Ausbildung von Giacomo Salvadore
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Università degli Studi di Roma Tor Vergata
 Università degli Studi di Roma Tor Vergata Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
